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Background
The duodenal mucosa protects itself from gastric acid
injury by the secretion of bicarbonate.
We determined a possible role of the cGMP-cGKI
pathway for the duodenal bicarbonate secretion by
studying conventional cGKI knockouts (cGKI-KOs) and
rescue mice (RM) that express either the cGKIa or b
isoform in SM22a positive smooth muscle cells [1].
Results
Gastric acid production was similar in control and
mutant mice. The basal secretion rate of bicarbonate
was strongly reduced in the different gene-targeted
cGKI mice.
Protons induced bicarbonate secretion in controls
but not in mutant mice. The dysfunction of the duode-
nal bicarbonate secretion of RM and cGKI-KO animals
was associated with severe gastrointestinal bleedings,
which were caused by the age-dependent aggravation
of an epithelial ulceration that localized to the papilla
Vateri.
In conclusion, the analysis of cGKI-KO and RM indi-
cates that a cGMP-cGKI-dependent pathway is present
in non-smooth muscle cells of the duodenum, that is
involved in the basal and acid-induced secretion of
bicarbonate. We suppose, that cGKI might be
expressed in the enteric nervous system. Furthermore
we hypothesize a crucial role for cGKI signaling via
the N. vagus.
In contrast to the widespread assumption, that cGKI is
expressed in duodenal cells of Cajal we were not able to
detect any cGKI in these cells.
Conclusion
The inability to secrete adequate amounts of bicarbo-
nate ultimately leads to duodenal ulceration. We postu-
late that the continuous blood loss accounts for the
chronic anemia of cGKI mutant mice and causes the
premature death of the cGKI-KOs and RM.
To administer a therapy against the ulceration and
their effects, cGKI knockout mice were treated with a
proton pump inhibitor. Chronical treatment of conven-
tional cGKI knockout mice with the proton pump inhi-
bitor esomeprazol prolonged their life expectancy
significantly in contrast to the untreated cGKI-knockout
mice.
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